Levo-M Quinolones

Levofloxacin is a third generation fluoroquinolones; an inhibitor of bacterial topoisomerase IV and DNA gyrase 

Levo-M

Levo-M Levofloxacin (as hemihydrate) 250 mg

  • Dosage and administration

    Adults

    Dosage in patients with normal renal function

    Infection  

    Dose

    Duration (days)  

    Community acquired pneumonia

    500 mg OD or BID

    7-14

    Complicated skin and soft tissue infections

    500 mg OD or BD

    7-14

    Chronic bacterial prostatitis

    500 mg OD

    28

    Inhalational anthrax (Post-Exposure)

    500 mg OD

    56

    Uncomplicated cystitis

    250 mg OD

    3

    Acute bacterial exacerbation of chronic bronchitis

    500 mg OD

    7-10

    Acute pyelonephritis

    500 mg OD

    7-10

    Complicated urinary tract infection

    500 mg OD

    7-14

    Acute bacterial sinusitis

    500 mg OD

    10-14
  • Contraindications
    • Known hypersensitivity to levofloxacin or other quinolones.
    • Epilepsy
    • In patients with history of tendon disorder related to fluoroquinolone administration
    • In children or growing adolescents.